human ang 2 (Sino Biological)
Structured Review
Human Ang 2, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+ang+2/Human+ANG2+%2F+Angiopoietin-2+Protein/10__1016_slash_j__biopha__2025__118690-59-46-49
Average 94 stars, based on 6 article reviews
Images
Related Articles
Blocking Assay:Article Title: GB10, a novel antibody fusion protein targeting VEGF/Ang-2, exhibits promising therapeutic efficacy for neovascular eye diseases Article Snippet: A Nunc 96-well Maxisorp plate was coated with recombinant human VEGF-A165 (C083, Novoprotein, 200 ng/well) overnight at 4 °C. .. The next day, after blocking with blocking solution, 3-fold serially diluted samples ranging from 18 nM to 0.0009 nM were added and incubated at 37 ◦C for 1 h. After washing three times with PBST, Article Title: GB10, a novel antibody fusion protein targeting VEGF/Ang-2, exhibits promising therapeutic efficacy for neovascular eye diseases Article Snippet: The wells of Nunc 96-well Maxisorp plates were coated with 100 ng of Tie-2 in coating buffer (C1050, Solarbio) and incubated at 4 °C overnight. .. The next day, after blocking with blocking buffer (SW3015, Solarbio) at 37 °C for 2 h, the plates were washed three times with PBST (phosphate-buffered saline containing 0.05 % Tween-20), then 3-fold serially diluted samples ranging from 20 nM to 0.0003 nM pre-incubated with 100 ng/mL Incubation:Article Title: GB10, a novel antibody fusion protein targeting VEGF/Ang-2, exhibits promising therapeutic efficacy for neovascular eye diseases Article Snippet: A Nunc 96-well Maxisorp plate was coated with recombinant human VEGF-A165 (C083, Novoprotein, 200 ng/well) overnight at 4 °C. .. The next day, after blocking with blocking solution, 3-fold serially diluted samples ranging from 18 nM to 0.0009 nM were added and incubated at 37 ◦C for 1 h. After washing three times with PBST, Article Title: GB10, a novel antibody fusion protein targeting VEGF/Ang-2, exhibits promising therapeutic efficacy for neovascular eye diseases Article Snippet: The wells of Nunc 96-well Maxisorp plates were coated with 100 ng of Tie-2 in coating buffer (C1050, Solarbio) and incubated at 4 °C overnight. .. The next day, after blocking with blocking buffer (SW3015, Solarbio) at 37 °C for 2 h, the plates were washed three times with PBST (phosphate-buffered saline containing 0.05 % Tween-20), then 3-fold serially diluted samples ranging from 20 nM to 0.0003 nM pre-incubated with 100 ng/mL Saline:Article Title: GB10, a novel antibody fusion protein targeting VEGF/Ang-2, exhibits promising therapeutic efficacy for neovascular eye diseases Article Snippet: The wells of Nunc 96-well Maxisorp plates were coated with 100 ng of Tie-2 in coating buffer (C1050, Solarbio) and incubated at 4 °C overnight. .. The next day, after blocking with blocking buffer (SW3015, Solarbio) at 37 °C for 2 h, the plates were washed three times with PBST (phosphate-buffered saline containing 0.05 % Tween-20), then 3-fold serially diluted samples ranging from 20 nM to 0.0003 nM pre-incubated with 100 ng/mL Enzyme-linked Immunosorbent Assay:Article Title: GB10, a novel antibody fusion protein targeting VEGF/Ang-2, exhibits promising therapeutic efficacy for neovascular eye diseases Article Snippet: The wells of Nunc 96-well Maxisorp plates were coated with 100 ng of Tie-2 in coating buffer (C1050, Solarbio) and incubated at 4 °C overnight. .. The next day, after blocking with blocking buffer (SW3015, Solarbio) at 37 °C for 2 h, the plates were washed three times with PBST (phosphate-buffered saline containing 0.05 % Tween-20), then 3-fold serially diluted samples ranging from 20 nM to 0.0003 nM pre-incubated with 100 ng/mL Adjuvant:Article Title: GB10, a novel antibody fusion protein targeting VEGF/Ang-2, exhibits promising therapeutic efficacy for neovascular eye diseases Article Snippet: .. One alpaca was immunized with 500 μg |
